YaSheng Group
HERB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,831 | $9,666 | $16,220 | $13,831 |
| - Cash | $8,530 | $6,077 | $4,176 | $3,752 |
| + Debt | $232 | $2,051 | $1,686 | $2,234 |
| Enterprise Value | $5,533 | $5,639 | $13,730 | $12,312 |
| Revenue | $24,148 | $21,137 | $18,589 | $14,014 |
| % Growth | 14.2% | 13.7% | 32.6% | – |
| Gross Profit | $8,079 | $7,041 | $5,587 | $4,013 |
| % Margin | 33.5% | 33.3% | 30.1% | 28.6% |
| EBITDA | $7,659 | $7,417 | $5,209 | $3,758 |
| % Margin | 31.7% | 35.1% | 28% | 26.8% |
| Net Income | $8,069 | $7,017 | $5,307 | $3,717 |
| % Margin | 33.4% | 33.2% | 28.6% | 26.5% |
| EPS Diluted | 0.051 | 0.045 | 0.034 | 0.022 |
| % Growth | 15% | 32% | 57.2% | – |
| Operating Cash Flow | $5,492 | $3,772 | $2,399 | $2,440 |
| Capital Expenditures | -$2,753 | -$1,051 | -$2,001 | -$500 |
| Free Cash Flow | $2,739 | $2,721 | $398 | $1,940 |